Ticagrelor Use in Stroke Patients: Past, Present, and Future by Chandra R, Saini H, Cerejo R, Tayal A, Malhotra K

Subjects: Get full text

Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome by Yuting Zou, Yuyan Wang, Yangxun Wu, Shizhao Zhang, Haiping Liu, Tong Yin

Subjects: Get full text

Apolipoprotein A-I, elevated in trauma patients, inhibits platelet activation and decreases clot strength by Wilbert L. Jones, Christopher R. Ramos, Anirban Banerjee, Ernest E. Moore, Kirk C. Hansen, Julia R. Coleman, Marguerite Kelher, Keith B. Neeves, Christopher C. Silliman, Jorge Di Paola, Brian Branchford

Subjects: Get full text

Sex Differences in Platelet Reactivity in Patients With ST-Elevation Myocardial Infarction: A Sub-Analysis of the ON-TIME 3 Trial by Anne H. Tavenier, Renicus S. Hermanides, Jan Paul Ottervanger, Svetlana V. Belitser, Olaf H. Klungel, Yolande Appelman, Maarten A.H. van Leeuwen, Arnoud W.J. van 't Hof, Arnoud W.J. van 't Hof, Arnoud W.J. van 't Hof

Subjects: Get full text

Excess Mortality in Aspirin and Dipyrone (Metamizole) Co‐Medicated Patients With Cardiovascular Disease: A Nationwide Study by Amin Polzin, Lisa Dannenberg, Carolin Helten, Martin Pöhl, Daniel Metzen, Philipp Mourikis, Christof Dücker, Ursula Marschall, Helmut L’Hoest, Beata Hennig, Saif Zako, Kajetan Trojovsky, Tobias Petzold, Christian Jung, Bodo Levkau, Tobias Zeus, Karsten Schrör, Thomas Hohlfeld, Malte Kelm

Subjects: Get full text

Tirofiban potentiates agonist-induced platelet activation and degranulation, despite effectively inhibiting aggregation by Martina Aguiar Bucsai, Christian Idel, Barbara Wollenberg, Christine Mannhalter, Admar Verschoor

Subjects: Get full text

The potency of selatogrel, a reversible antagonist of the P2Y12 receptor, is affected by calcium concentration by Martine Baumann, Benoît Lack, Isabelle Guillaumat, Mark J. Murphy, Markus A. Riederer

Subjects: Get full text

Cangrelor in contemporary patients with ST-segment elevation myocardial infarction pretreated with Ticagrelor: Pharmacodynamic data from the POMPEII study by Giuseppe Gargiulo, Plinio Cirillo, Luca Sperandeo, Imma Forzano, Domenico Simone Castiello, Domenico Florimonte, Fiorenzo Simonetti, Roberta Paolillo, Lina Manzi, Alessandra Spinelli, Carmen Anna Maria Spaccarotella, Raffaele Piccolo, Luigi Di Serafino, Anna Franzone, Piera Capranzano, Marco Valgimigli, Giovanni Esposito

Subjects: Get full text

Rivaroxaban reduces thromboxane induced platelet aggregation - the forgotten compass arm? by Lisa Dannenberg, René M‘Pembele, Philipp Mourikis, Carolin Helten, Saif Zako, Samantha Ahlbrecht, Hannah Richter, Dorothee Zikeli, Marcel Benkhoff, Ragnar Huhn-Wientgen, Manuela Thienel, Bodo Levkau, Malte Kelm, Tobias Petzold, Amin Polzin

Subjects: Get full text

Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry by A. Selvarajah, A. H. Tavenier, W. L. Bor, V. Houben, S. Rasoul, E. Kaplan, K. Teeuwen, S. H. Hofma, E. Lipsic, G. Amoroso, M. A. H. van Leeuwen, J. M. ten Berg, A. W. J. van ‘t Hof, R. S. Hermanides

Subjects: Get full text

No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan‐induced inhibition of platelet aggregation response by Maria J. Reimann, Daniel N. Faisst, Mads Knold, Kathryn M. Meurs, Joshua A. Stern, Signe E. Cremer, Jacob E. Møller, Ingrid Ljungvall, Jens Häggström, Lisbeth H. Olsen

Subjects: Get full text

Risk factors for hemorrhage in patients with long-term aspirin therapy undergoing emergency external ventricular drainage/intracranial pressure probe placement by Fei Gao, Shunnan Ge, Wenxing Cui, Jingya Zhao, Yang Yang, Wei Guo, Hao Bai, Bao Wang, Chen Yang, Shijie Mu, Liang Wang, Tianzhi Zhao, Yan Qu, Yaning Cai

Subjects: Get full text

Advanced pharmacodynamics of cangrelor in healthy volunteers: a dose-finding, open-label, pilot trial by Georg Gelbenegger, Juergen Grafeneder, Gloria M. Gager, Jolanta M. Siller-Matula, Michael Schwameis, Bernd Jilma, Christian Schoergenhofer

Subjects: “…Platelet inhibition…”
Get full text

Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microR... by William A. E. Parker, Christian Schulte, Temo Barwari, Fladia Phoenix, Sam M. Pearson, Manuel Mayr, Peter J. Grant, Robert F. Storey, Ramzi A. Ajjan

Subjects: Get full text

Panax quinquefolius saponins combined with dual antiplatelet therapy enhanced platelet inhibition with alleviated gastric injury via regulating eicosanoids metabolism by Wenting Wang, Lei Song, Lin Yang, Changkun Li, Yan Ma, Mei Xue, Dazhuo Shi

Subjects: Get full text

Platelet Inhibition, Endothelial Function, and Clinical Outcome in Patients Presenting With ST‐Segment–Elevation Myocardial Infarction Randomized to Ticagrelor Versus Prasugrel Mai... by Nina W. van der Hoeven, Gladys N. Janssens, Henk Everaars, Alexander Nap, Jorrit S. Lemkes, Guus A. de Waard, Peter M. van de Ven, Albert C. van Rossum, Javier Escaned, Hernan Mejia‐Renteria, Tim J. F. ten Cate, Jan J. Piek, Clemens von Birgelen, Marco Valgimigli, Roberto Diletti, Niels P. Riksen, Nicolas M. Van Mieghem, Robin Nijveldt, Maarten A. H. van Leeuwen, Niels van Royen

Subjects: Get full text

The use of CytoSorb® in a prasugrel‐loaded patient undergoing emergent coronary artery bypass graft surgery by Erich Moresco, Hannes Dejaco, Volker Humbert, Matthias Thoma

Subjects: “…prasugrel, multiplate, platelet inhibition…”
Get full text

Mind the Gap: Platelet Inhibition in Low‐Risk Acute Coronary Syndrome Undergoing Percutaneous Revascularization by Ravi K. Sharma, Duane S. Pinto

Subjects: Get full text

Relation of Level of Platelet Inhibition after Eptifibatide with Major Cardiovascular Events in ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Cor... by Elisa Feriyanti Pakpahan, Sunarya Soerianata, Nur Haryono

Subjects: Get full text

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation by . .

Subjects: Get full text